03/25/2025
11:15 PM | Omega Therapeutics (Filer)
| Form EFFECT | |
03/20/2025
3:04 PM | Omega Therapeutics (Filer)
| Form 25
Notification of the removal from listing and registration of matured, redeemed or retired securities | |
03/07/2025
8:57 AM | FMR LLC (Filed by)
Omega Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/24/2025
3:48 PM | Omega Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2025
3:40 PM | Flagship V VentureLabs Rx Fund, L.P. (Filed by)
Omega Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
02/05/2025
2:57 PM | Omega Therapeutics (Subject)
Young Richard A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/04/2025
8:59 PM | Omega Therapeutics (Issuer)
Varsalone Jeffrey T (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/17/2025
4:00 PM | Omega Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
3:47 PM | Omega Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/31/2024
4:37 PM | Flagship Ventures Fund V, L.P. (Filed by)
Omega Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
12/31/2024
4:30 PM | Omega Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2024
4:00 PM | Omega Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2024
3:05 PM | Mehrotra Ravi (Reporting)
Omega Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/26/2024
5:27 PM | Nelson Jennifer Ann (Reporting)
Omega Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/26/2024
5:31 PM | Nelson Jennifer Ann (Reporting)
Omega Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
5:09 PM | Certel Kaan (Reporting)
Omega Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:10 PM | Omega Therapeutics (Issuer)
Rosiello Robert L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:00 PM | Omega Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
4:01 PM | Omega Therapeutics (Issuer)
Rosiello Robert L. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/30/2024
3:01 PM | Omega Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
6:02 AM | Omega Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
6:03 AM | Omega Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/21/2024
3:15 PM | Kender Richard N (Reporting)
Omega Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
Buy OMGA Stock Free OMGA Stock Alerts